Liraglutide May Ease Peripheral Artery Disease in T2D Liraglutide May Ease Peripheral Artery Disease in T2D

The drug significantly increased peripheral perfusion over 6 months compared with conventional cardiovascular risk factor treatment.Medscape UK

Source: Medscape Cardiology Headlines - March 19, 2024 Category: Cardiology Tags: Diabetes & Endocrinology Source Type: news